Treatment of paraneoplastic visual loss with intravenous immunoglobulin: Report of 3 cases

Archives of Ophthalmology

Volumn 117, Issue 4, 1999, Pages 471-477

  Guy, John ^a   Aptsiauri, Nata ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISONE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CASE REPORT; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LUNG ADENOCARCINOMA; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PANCREAS ADENOCARCINOMA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RETINOPATHY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 0032953177     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.4.471     Document Type: Article

References (36)

1. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81: 606-613.
2. Kornguth SE, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 1982; 50:1289-1293.
3. Keltner JL, Roth AM, Chang S. Photoreceptor degeneration. Arch Ophthalmol. 1983;101:564-569.
4. Buchanan TAS, Gardiner TA, Archer DB. An ultrastructural study of retinal Photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol. 1984;97:277-287.
5. Klingele TG, Burde RM, Rappazzo JA, et al. Paraneoplastic retinopathy. J Clin Neuro-ophthalmol. 1984;4:239-245.
6. Grunwald GB, Kornguth SE, Towfighi J, et al. Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Cancer. 1987; 60:780-786.
7. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372-375.
8. Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol. 1990;28:162-167.
9. Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110:48-53.
10. Gehrs K, Tiedeman J. Hemeralopia in an older adult. Surv Ophthalmol. 1992;37: 185-189.
11. Rizzo JF III, Gittinger JW. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology. 1992;99:1286-1295.
12. Ohnishi Y, Ohara S, Sakamoto T, Kohno T, Nakao F. Cancer-associated retinopathy with retinal phlebitis. Br J Ophthalmol. 1993;77:795-798.
13. Crofts JW, Bachynski BN, Odel JG. Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma. Can J Ophthalmol. 1988;23:128-132.
14. Eltabbakh GH, Hoogerland DL, Kay MC. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol. 1995;58:120-123.
15. Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: a novel auto-antibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol. 1997;17:77-83.
16. Pengel J, Crevits L, Wynants P, et al. Optic nerve metastasis simulating optic neuritis. Clin Neurol Neurosurg. 1997;99:46-49.
17. Arnold AC, Hepler RS, Foos RY. Isolated metastasis to the optic nerve. Surv Ophthalmol. 1981;26:75-83.
18. Guy J, Mancuso A, Beck R, et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg. 1991;74:426-432.
19. Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology. 1985; 92:1118-1126.
20. Adamus G, Guy J, Schmied JL, Arendt A, Margrave PA. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1993; 34:2626-2633.
21. Adamus G, Aptsiauri N, Heckenlively J, Flannery J, Hargrave PA. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol. 1996;78:120-129.
22. Suzuki T, Obara Y, Sato Y, et al. Cancer-associated retinopathy with presumed vasculitis. Am J Ophthalmol. 1996;122:125-127.
23. Ohkawa T, Kawashima H, Makino S, et al. Cancer-associated retinopathy in a patient with endometrial cancer. Am J Ophthalmol. 1996;122:740-742.
24. Moll JWB, Henzen-Logmans SC, Van Der Meche FGA, Vecht CHJ. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry. 1993;56:112-115.
25. Uchuya M, Graus F, Vega F, Rene R, Delattre JY. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry. 1996;60:388-392.
26. van Engelen BGM, Hommes OR, Pinckers A, et al. Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol. 1992; 32:834-835.
27. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology. 1988; 38:1391-1398.
28. Dalmau J, Graus F, Rosenblum MK, Poisson M, Delattre JY. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy: a clinical study of 71 patients. Medicine. 1992;71:59-72.
29. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration, I: a clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42:1931-1937.
30. Dalmau J, Posner JB. Neurologic-paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology. 1994;44:2241-2246.
31. Bain PG, Motomura M, Newsom-Davis J, et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology. 1996;47:678-683.
32. Malik S, Furlan AJ, Sweeney PJ, Kosmorsky GS, Wong M. Optic neuropathy: a rare paraneoplastic syndrome. J Clin Neuro-ophthalmol. 1992;12:137-141.
33. Boghen D, Sebag M, Michaud J. Paraneoplastic optic neuritis and encephalomyelitis: report of a case. Arch Neurol. 1988;45:353-356.
34. Waterston JA, Gilligan BS. Paraneoplastic optic neuritis and external ophthalmoplegia. Aust N Z J Med. 1986;16:703-704.
35. Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med. 1997;126:721-730.
36. Brannagan TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin treatment in neurologic disease. Neurology. 1996;47:674-677.